[Enkephalinergic regulation of cardiovascular centers].
D000818:Animals; D001794:Blood Pressure; D001931:Brain Mapping; D002320:Cardiovascular Physiological Phenomena; D002415:Cats; D003916:Dextromoramide / Q000494:pharmacology; D004285:Dogs; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000494:pharmacology; D004745:Enkephalins / Q000494:pharmacology / Q000502:physiology*; D006339:Heart Rate; D008526:Medulla Oblongata / Q000502:physiology; D009270:Naloxone / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology; D009424:Nervous System Physiological Phenomena; D011311:Pressoreceptors / Q000502:physiology; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology; D012018:Reflex / Q000502:physiology; D012154:Reticular Formation / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology; D014630:Vagus Nerve / Q000502:physiology; D014666:Vasomotor System / Q000502:physiology
D004745:Enkephalins; D011957:Receptors, Opioid; D009270:Naloxone; D004744:Enkephalin, Methionine; D009271:Naltrexone; C022118:enkephalinamide-Met, Ala(2)-; C037423:enkephalinamide-Met sulfoxide, Ala(2)-; D003916:Dextromoramide
Régulation enképhalinergique des centres cardiovasculaires.